Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Scientists Create Model of Beating Heart Muscle

By Biotechdaily staff writers
Posted on 12 Aug 2002
A bioengineered, experimental model of rhythmically beating heart muscle has been produced by the collaborative effort of a cardiologist and an orthopedist at the University of North Carolina at Chapel Hill (UNC, USA). More...
They presented their model at the World Congress of Biomechanics in Calgary (Canada).

The model is a bioartificial trabeculum, or BAT. Trabecula are thin sections of cardiac tissue within the inner surface of the main pumping chambers of the heart. The model may prove to be a valuable tool for exploring cardiac disease or to generate tissue patches that might be applied to the surface of the heart or incorporated into a diseased heart as therapy.

Dr.Albert J. Banes, UNC professor of orthopedics, had earlier developed a special tissue plate used as a framework in which cells in a liquid collagen gel could remodel to form a more tissue-like structure. "We thought it would be better to grow cells in a dynamic environment, on a flexible substrate.”

Dr. Wayne E. Cascio, UNC associate professor of medicine, thought they could grow cardiac myocytes and make a cardiac muscle tissue-like material to test in culture. In developing the tissue model, Dr. Cascio and an assistant isolated cardiac myocytes from one-day-old rats. These were mixed in a solution of collagen and serum and allowed to gel under incubation in the special tissue plate developed by Dr. Banes. After four days in culture, the heart cells migrated toward the center of the gel to form a dense cord of tissue that extended between two tethers.

The tissue strand rhythmically contracts at 100 beats per minute, easily observed with a low-power microscope, say the researchers. Tests reveal striations and cell-to-cell coupling characteristic of cardiac tissue. "In my lab, we're specifically interested in generating cardiac myocytes with certain electrical or contractile properties by manipulating the genetics of the cells and then reforming them into functional tissue to assess their properties,” said Dr. Cascio.




Related Links:
University of North Carolina

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
hCG Whole Blood Pregnancy Test
VEDALAB hCG-CHECK-1
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.